ANDA 83546, held by Watson Labs. Estradiol Valerate.
As of Nov 16, 2026, ANDA 83546 (Estradiol Valerate), held by Watson Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Estradiol Valerate10MG/ML ยท injectable;injection | Estradiol Valerate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters